Diclofenac Epolamine Patent Expiration
Diclofenac Epolamine was first introduced by Ibsa Institut Biochimique Sa
Diclofenac Epolamine Patents
Given below is the list of patents protecting Diclofenac Epolamine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Licart | US11344520 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | Feb 20, 2035 | Ibsa Inst Bio |
| Licart | US11351133 | Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug | Feb 20, 2035 | Ibsa Inst Bio |
| Flector | US5607690 | External anti-inflammatory and analgesic plaster preparation |
Apr 13, 2014
(Expired) | Ibsa |
Diclofenac Epolamine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List